Abbott Clinches Wockhardt's Nutritional Business In Bid To Bolster Presence In India
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Beleaguered Indian biopharmaceutical company, Wockhardt announced its third transaction in six months that it sold its entire nutritional business to U.S. pharmaceutical firm Abbott for $130 million. For Abbott, the deal brings in a few strong brands, the nutritional manufacturing facilities in Lalru and Jagraon - two small towns in Northern India - Carol Info Services and certain subsidiaries and group companies of Wockhardt
You may also be interested in...
Danone Gets Second Time Lucky, Buys Wockhardt's Nutrition Brands That Abbott Had Won And Lost
HYDERABAD, India - After several months of discussions, debt-laden Indian drug maker Wockhardt Ltd. finally managed to sell its growing nutritional business to French food giant Group Danone for reportedly $354 million - a quantum jump from the $130 million that Abbott Laboratories Ltd. had agreed to pay for the same assets exactly two years ago
Danone Gets Second Time Lucky, Buys Wockhardt's Nutrition Brands That Abbott Had Won And Lost
HYDERABAD, India - After several months of discussions, debt-laden Indian drug maker Wockhardt Ltd. finally managed to sell its growing nutritional business to French food giant Group Danone for reportedly $354 million - a quantum jump from the $130 million that Abbott Laboratories Ltd. had agreed to pay for the same assets exactly two years ago
Abbott, GSK, And Heinz Vying Again For Indian Wockhardt's Nutrition Brands
MUMBAI - An interesting bidding battle is said to be brewing for Wockhardt's nutrition products business, which includes well-known consumer brands like health supplement Protinex and pediatric nutrition brands like Farex, Dexolac and Nusobee